Timothy McCavit, MD

Hematologist

Language(s):

English

Cook Children's Hematology and Oncology

1500 Cooper St

Fort Worth

TX 76104

Get directions

| View all locations

Make an appointment Call (682) 885-4007

Jump to:
About me
Services
Locations
Education
Ratings
Research & publications

Meet Dr. Timothy McCavit

Timothy L. McCavit, M.D., M.S.C.S., is a hematology/oncology physician with Cook Children's Medical Center, in Ft. Worth, Texas. He received a B.S. in molecular biology from Texas Tech University in 1998 and an M.D. from UT Southwestern Medical Center in 2002. He completed post-graduate medical training at UT Southwestern in 2009 (residency and fellowship) and an M.S. in Clinical Sciences from UT Southwestern in 2013.

Dr. McCavit has diverse interests in benign hematology. His chief focus is on the care of children with bleeding disorders as he directs the Bleeding Disorder Program and Hemophilia Treatment Center at Cook Children's. In addition to caring for children with complex bleeding disorders, Dr. McCavit has an interest and expertise in the care of children with hemoglobinopathy including sickle cell disease and thalassemia. He has a specific interest and expertise in the care of children with iron deficiency anemia – particularly refractory or difficult-to-treat cases. He is forward-thinking with the use of intravenous iron for children with refractory iron deficiency anemia.

Dr. McCavit has been active in the American Society of Hematology where he served on the Quality Committee from 2011 – 2017. He has published research investigating quality-of-care indicators for children with both sickle cell disease and cancer (febrile neutropenia). Further, he has published research in sickle cell disease and iron deficiency anemia including a landmark paper comparing to commonly used forms of oral iron for iron deficiency anemia published in JAMA in June 2017.

Clinic webpage Dr. Timothy McCavit's team

Services

Blood disorder diagnosis and care
Outpatient and inpatient services

All Practice Locations

Cook Children's Hematology and Oncology

1500 Cooper St.

5th Floor

Fort Worth

TX 76104

Main Number

(682) 885-4007

Affiliations

Cook Children's Physician Network

Education

Medical School:

1998-2002 M.D., University of Texas Southwestern Medical Center, Dallas, TX; 2009-2013 M.S., Clinical Sciences, University of Texas Southwestern Medical Center, Dallas, TX

Residency:

2002-05 Department of Pediatrics, University of Texas - Southwestern Medical Center & Children’s Medical Center|2005-06 Chief Resident, Department of Pediatrics, University of Texas - Southwestern Medical Center & Children’s Medical Center

Board Certifications:

American Board of Pediatric Hematology/Oncology

Research & Publications

Publications:

McCavit T, Grube S, Revell P, Quinn CT. Bordetella holmesii bacteremia in children with sickle cell disease. Pediatric Blood & Cancer, 51(6):814-6, 2008. PMID: 18680153
Quinn CT, Rogers ZR,McCavit TL, Buchanan GR. Improved survival of children and adolescents with sickle cell disease. Blood, 115(17):3447-52, 2010. PMID: 20194891McCavit TL, Quinn CT, Techasaensiri C, Rogers ZR. Increase in Invasive Streptococcus pneumoniae Infections in Children with Sickle Cell Disease since Pneumococcal Conjugate Vaccine Licensure. Journal of Pediatrics, 158(3):505-7, 2011. PMID: 21193205
McCavit TL, Lin H, Zhang S, Ahn C, Quinn CT, Flores G. Hospital Volume, Hospital Teaching Status, Patient Socioeconomic Status, and Outcomes in Patients Hospitalized with Sickle Cell Disease. American Journal of Hematology, 86(4):377-380, 2011. PMID: 21442644
McCavit TL, Winick NJ. Time-to-Antibiotic Administration as a Quality of Care Measure in Pediatric Febrile Neutropenia: A Survey of Pediatric Oncology Centers. Pediatric Blood & Cancer, 58(2):303-5, 2012. PMID: 21509930 McCavit TL, Xuan L, Zhang S, Flores G, Quinn CT. Hospitalization for Invasive Pneumococcal Disease in a National Sample of Children with Sickle Cell Disease Before and After PCV7 Licensure. Pediatric Blood & Cancer, 58(6):945-9, 2012. PMID: 21793185
McCavit TL. Sickle Cell Disease. Pediatrics-In-Review, 33(5):195-204, 2012. PMID: 22550263
Mittal V, Krieger E, Lee BC, Kind T, McCavit TL, Campbell J, Ottolini MC, Flores G. Pediatric Resident Perspectives on Family-Centered Rounds: A Qualitative Study at Two Children's Hospitals. Journal of Graduate Medical Education, 5(1):81-87, 2013. PMID: 24404232
McCavit TL, Xuan L, Zhang S, Flores G, Quinn CT. National Trend in Incidence Rates of Hospitalization for Stroke in Children with Sickle Cell Disease. Pediatric Blood and Cancer, 60(5):823-7, 2013. PMID: 23151905
McCavit TL, Gilbert M, Buchanan GR. Prophylactic Penicillin After 5 years of Age in Patients with Sickle Cell Disease: A Survey of Pediatric Sickle Cell Disease Experts. Pediatric Blood and Cancer, 60(6):935-9, 2013. PMID: 23193095
Fletcher M, Hodgkiss H, Zhang S, Browning R, Hadden C, Hoffman T, Winick N, McCavit TL. Prompt Administration of Antibiotics is Associated with Improved Outcomes in Febrile Neutropenia in Children with Cancer; Pediatric Blood and Cancer; 60(8):1299-1306, 2013. PMID: 23417978
Panepinto JA, Torres S, Bendo CB, McCavit TL, Dinu B, Sherman-Bien S, Bemrich-Stolz C, Varni JW. Peds QLTM Sickle Cell Disease Module: Feasibility, Reliability, and Validity. Pediatric Blood and Cancer, 60(8):1338-44, 2013. PMID: 23193095
Plummer ES, Crary SE, McCavit TL, Buchanan GR. Intravenous Low-Molecular Iron Dextran in Children with Iron Deficiency Anemia Unresponsive to Oral Iron; Pediatric Blood and Cancer, 60(11):1747-52, 2013. PMID: 23832487
Panepinto JA, Torres S, Bendo CB, McCavit TL, Dinu B, Sherman-Bien S, Bemrich-Stolz C, Varni JW. Peds QLTM multidemonsional fatigue scale in sickle cell disease: Feasibility, reliability, and validity. Pediatric Blood and Cancer, 61(1):171-7, 2014. PMID: 24038960
Simko SJ, Tran HD, Jones J, Bilgi M, Beaupin K, Coulter D, Garrington T, McCavit TL, Moore C, Rivera-Ortegon F, Shaffer L, Stork L, Turcotte L, Welsh EC, Hicks MJ, McClain KL, Allen CE. Clofarabine salvage therapy in refractory multifocal histiocytic disorders, including Langerhan's cell histiocytosis, juvenile xanthogranuloma, and Rosai-Dorfman disease. Pediatric Blood and Cancer, 61(3):479-87, 2014. PMID: 24106153
DeBaun MR, Gordon M, McKinstry RC, Noetzel MJ, White DA, Sarnaik SA, Meier ER, Howard TH, Majumdar S, Inusa PDB, Telfer PT, Kirby-Allen M, McCavit TL, Kamdem A, Airewele G, Woods GM, Berman B, et al. Controlled Trial of Transfusions for Sickle Cerebral Infarcts in Sickle Cell Anemia; New England Journal of Medicine, 371(8):699-710, 2014.
Wu SY, McCavit TL, Cederberg K, Galindo RL, Leavey PJ. Chemotherapy for Generalized Infantile Myofibromatosis with Visceral Involvement. Journal of Pediatric Hematology-Oncology; in press; March 2014.
Mathias M, McCavit TL. Time-to-Opioids as a Quality-of-Care Indicator for Acute Pain Crises in Sickle Cell Disease. Pediatrics, 135(3):475-82, 2015. PMID: 25667245.
Powers JM, McCavit TL, Buchanan GR. Management of Iron Deficiency Anemia: A Survey of Pediatric Hematology/Oncology Providers. Pediatric Blood and Cancer, 62(5):842-6, 2015. PMID: 25663613.
Telen MJ, Wun T, McCavit TL, De Castro LM, Krishnamurti L, Lanzkron S, Hsu LL, Smith WR,Rhee S, Magnani JL, Thackray H. Reduction In Time To Resolution Of Vaso-Occlusive Crisis and Decreased Opioid Use In a Phase 2 Study of GMI-1070 in Sickle Cell Disease. Blood, 125(17):2656-64, 2015. PMID: 25733584.
McCavit TL, Krishnamurti L, Hsu LL, Quinn CT, Odame I, Alvarez O, Driscoll C, Smith-Whitley K, Rhee S, Wun T, Telen MJ, Thackray H. An Analysis of the Pediatric Sub-group from the Phase 2 Study of GMI 1070 – A Novel Agent for the Vaso-Occlusive Crisis of Sickle Cell Anemia. In Preparation (Advanced draft circulated).
McCavit TL, Desai P. Acute Complications of Sickle Cell Disease - American Society of Hematology Pocket Guideline Clinical Reference – 2014.
Powers JM, Daniel CL, McCavit TL, Buchanan GR. Deficiencies in the Management of Iron Deficiency Anemia During Childhood. Pediatric Blood and Cancer, 63(4):743-5, 2016. PMID: 26728130.
Cooke AG, McCavit TL, Buchanan GR, Powers JM. Iron Deficiency Anemia in Adolescents Presenting with Heavy Menstrual Bleeding. Journal of Pediatric and Adolescent Gynecology, 30(2):247-50, 2017. PMID 27789349.
Powers JM, Shamoun M, McCavit TL, Adix L, Buchanan GR. Intravenous Ferric Carboxymaltose In Children with Iron Deficiency Anemia Who Respond Poorly to Oral Iron. Journal of Pediatrics, 180:212-6, 2017. PMID 27776750.
Powers JM, Buchanan GR, Adix L, Zhang S, Gao A, McCavit TL. Low Dose Ferrous Sulfate versus Iron Polysaccharide Complex in Young Children with Nutritional Iron Deficiency Anema: A Randomized Clinical Trial. JAMA, 317(22):2297-2304, 2017. PMID 28609534.
Jordan LC, Roberts Williams DO, Rodeghier MJ, Covert Greene BV, Ponisio MR, Casella JF, McKinstry RC, Noetzel MJ, Kirkham FJ, Meier ER, Fuh B, McNaull M, Sarnaik S, Majumdar S, McCavit TL, DeBaun MR. American Journal of Hematology93 (6):760-8, 2018. PMID 29520844.